Amturnide and Breastfeeding

There may be unknown risks associated with taking Amturnide (aliskiren-amlodipine-hydrochlorothiazide) while breastfeeding, as it is unknown whether all of the components in this drug pass through breast milk. Due to the potential problems that may occur in a nursing infant, the manufacturer recommends that women not take Amturnide while breastfeeding.

Amturnide Drug Information

Can Breastfeeding Women Take Amturnide?

Amturnide^® (aliskiren-amlodipine-hydrochlorothiazide) is a prescription medication used to treat high blood pressure. It contains amlodipine (Norvasc^®), aliskiren (Tekturna^®), and hydrochlorothiazide. It is not clear if this medication is safe for women to use while nursing. Therefore, you should talk with your healthcare provider before taking Amturnide if you are breastfeeding or plan to start.

More Information About Amturnide and Breastfeeding

Hydrochlorothiazide passes through breast milk, although doses lower than 50 mg per day are not thought to cause any problems (this is higher than the highest strength of hydrochlorothiazide in Amturnide). Higher doses may suppress breast milk production.

No research has been done to see if the other two active ingredients in Amturnide pass through breast milk in humans. The manufacturer recommends against taking this medication while breastfeeding.

Talking With Your Healthcare Provider

You should discuss breastfeeding and

Amturnide use with your healthcare provider. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, the two of you can make a shared decision that is right for you.